Java platform provider Azul has acquired Payara, an application server company focused on Jakarta EE, as the vendor looks to expand beyond the Java runtime and sell a broader, commercially supported ...

Java will be 30 years old in 2025. This is a good time to look back, but also forward.

Up to 3 million abandoned oil and gas wells litter the U.S. alone, and while many still contain oil or natural gas, the owners decided it wasn’t worth it to keep pumping. “They’ve tried everything,” ...

Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. It’s exactly 600 days from today, and you’re standing on the ...

Starting in autumn quarter 2025, the University will begin a multi-year restructuring of the undergraduate writing program, which had previously run concurrently with the humanities Core sequence.

Here's what you need to know to make the most of the partial solar eclipse on Sept. 21, as the moon takes a 'bite' out of the sun. When you purchase through links on our site, we may earn an affiliate ...

On Sept. 21, a day before the equinox, a partial solar eclipse will obscure up to 86% of the sun Getty The last eclipse of the year arrives on Sept. 21, with a partial solar eclipse offering dramatic ...

The biggest stories of the day delivered to your inbox.

September's full moon of 2025 will also be a very special blood moon set to rise on Sept. 7 — amid a total lunar eclipse and rare moment of totality. Here are some quick facts about the lunar eclipse ...

On the evening of September 7, the second (and final) total lunar eclipse of the year will take place—serving up the striking sight of a red “blood moon” in the sky across much of the world. Total ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...